TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy

por Gonzalez, Caleb, Williamson, Sarah, Gammon, Seth T., Glazer, Sarah, Rhee, Joon Haeng, Piwnica-Worms, David
Publicado 2023

Evaluation of (89)Zr-Labeled Anti-PD-L1 Monoclonal Antibodies Using DFO and Novel HOPO Analogues as Chelating Agents for Immuno-PET

por Radaram, Bhasker, Glazer, Sarah E., Yang, Ping, Li, Chia-Wei, Hung, Mien-Chie, Gammon, Seth T., Alauddin, Mian, Piwnica-Worms, David
Publicado 2023